[HEIM] QoQ Annualized Quarter Result on 31-Mar-2012 [#3]

Stock
[HEIM] HEINEKEN MALAYSIA BERHAD
Announcement Date
23-May-2012
Admission Sponsor
-
Sponsor
-
Financial Year
30-Jun-2012
Quarter
31-Mar-2012 [#3]
Profit Trend
QoQ- -4.95%
YoY- 13.3%
Quarter Report
Latest QR
Upcoming QR
HEIM's Result
HEIM's Financial Summary
View:
Show?
Annualized Quarter Result
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
Revenue 1,643,452 1,569,136 1,623,687 1,703,545 1,825,892 1,778,492 1,488,720 6.78%
PBT 327,970 303,072 276,981 306,806 322,770 294,428 242,883 22.05%
Tax -81,992 -75,764 -69,582 -76,721 -80,708 -73,596 -61,505 21.02%
NP 245,978 227,308 207,399 230,085 242,062 220,832 181,378 22.40%
-
NP to SH 245,978 227,308 207,399 230,085 242,062 220,832 181,378 22.40%
-
Tax Rate 25.00% 25.00% 25.12% 25.01% 25.00% 25.00% 25.32% -
Total Cost 1,397,474 1,341,828 1,416,288 1,473,460 1,583,830 1,557,660 1,307,342 4.52%
-
Net Worth 335,328 438,042 380,643 374,601 504,503 570,804 516,582 -24.93%
Dividend
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
Div 120,839 - 377,622 281,958 422,937 - 163,131 -18.05%
Div Payout % 49.13% - 182.08% 122.55% 174.72% - 89.94% -
Equity
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
Net Worth 335,328 438,042 380,643 374,601 504,503 570,804 516,582 -24.93%
NOSH 302,098 302,098 302,098 302,098 302,098 302,013 302,095 0.00%
Ratio Analysis
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
NP Margin 14.97% 14.49% 12.77% 13.51% 13.26% 12.42% 12.18% -
ROE 73.35% 51.89% 54.49% 61.42% 47.98% 38.69% 35.11% -
Per Share
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
RPS 544.01 519.41 537.47 563.90 604.40 588.88 492.80 6.78%
EPS 81.42 75.24 68.65 76.16 80.12 73.12 60.04 22.40%
DPS 40.00 0.00 125.00 93.33 140.00 0.00 54.00 -18.05%
NAPS 1.11 1.45 1.26 1.24 1.67 1.89 1.71 -24.93%
Adjusted Per Share Value based on latest NOSH - 302,098
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
RPS 544.01 519.41 537.47 563.90 604.40 588.71 492.79 6.78%
EPS 81.42 75.24 68.65 76.16 80.12 73.10 60.04 22.40%
DPS 40.00 0.00 125.00 93.33 140.00 0.00 54.00 -18.05%
NAPS 1.11 1.45 1.26 1.24 1.67 1.8895 1.71 -24.93%
Price Multiplier on Financial Quarter End Date
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
Date 31/12/12 28/09/12 29/06/12 30/03/12 30/12/11 30/09/11 30/06/11 -
Price 16.60 15.26 13.36 13.08 13.46 9.92 10.14 -
P/RPS 3.05 2.94 2.49 2.32 2.23 1.68 2.06 29.74%
P/EPS 20.39 20.28 19.46 17.17 16.80 13.57 16.89 13.31%
EY 4.91 4.93 5.14 5.82 5.95 7.37 5.92 -11.67%
DY 2.41 0.00 9.36 7.14 10.40 0.00 5.33 -40.94%
P/NAPS 14.95 10.52 10.60 10.55 8.06 5.25 5.93 84.71%
Price Multiplier on Announcement Date
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
Date 07/03/13 21/11/12 28/08/12 23/05/12 23/02/12 02/11/11 04/08/11 -
Price 16.92 16.60 15.76 13.00 12.64 10.74 10.86 -
P/RPS 3.11 3.20 2.93 2.31 2.09 1.82 2.20 25.82%
P/EPS 20.78 22.06 22.96 17.07 15.77 14.69 18.09 9.63%
EY 4.81 4.53 4.36 5.86 6.34 6.81 5.53 -8.84%
DY 2.36 0.00 7.93 7.18 11.08 0.00 4.97 -38.99%
P/NAPS 15.24 11.45 12.51 10.48 7.57 5.68 6.35 78.78%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment